MedTrace Logo

Patient Registry for Patients With Chronic Subdural Hematoma

NCT04170582 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 250

Last updated 2023-03-02

No results posted yet for this study

Summary

All admitted patients diagnosed with unilateral or bilateral chronic subdural hematoma are included into this registry after consent. Clinical condition, radiological details, therapy (intervention/medication treatment/conservative) and outcome are documented. Patient follow-up is documented over at least 24 month with focus on neurological condition (NIHSS), cognitive impairment (MoCA) and quality of life (SF-12 ver. 2).

Conditions

  • Hematoma
  • Subdural Hematoma
  • Chronic

Sponsors & Collaborators

  • Heinrich-Heine University, Duesseldorf

    lead OTHER

Principal Investigators

  • Kerim Beseoglu, MD, PhD · Neurosurgery, Heinrich-Heine-University Düsseldorf, Medical Faculty

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-01-01
Primary Completion
2024-12-31
Completion
2025-01-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04170582 on ClinicalTrials.gov